Cargando…

Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133(+) pancreatic cancer stem-like cells

The initiation and progression of various solid tumors, including pancreatic carcinoma, are driven by a population of cells with stem cell properties, namely cancer stem cells (CSCs). Like their normal counterparts, CSCs are also believed to rely on their own microenvironment termed niches to sustai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Haitao, Wang, Dongqing, Liu, Yanfang, Su, Zhaoliang, Zhang, Lirong, Chen, Fangfang, Zhou, Yuepeng, Wu, Yingying, Yu, Ming, Zhang, Zhijian, Shao, Genbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177138/ https://www.ncbi.nlm.nih.gov/pubmed/24305593 http://dx.doi.org/10.1186/1475-2867-13-119

Ejemplares similares

CCL21/CCR7 Axis Contributed to CD133(+) Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway
por: Zhang, Lirong, et al.
Publicado: (2016)

The Low Chamber Pancreatic Cancer Cells Had Stem-Like Characteristics in Modified Transwell System: Is It a Novel Method to Identify and Enrich Cancer Stem-Like Cells?
por: Wang, Dongqing, et al.
Publicado: (2014)

Aptamer-PEG-modified Fe(3)O(4)@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells
por: Zhu, Haitao, et al.
Publicado: (2016)

Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness
por: Zhang, Lirong, et al.
Publicado: (2019)

The ionophore antibiotic gramicidin A inhibits pancreatic cancer stem cells associated with CD47 down-regulation
por: Wang, Rui-Qi, et al.
Publicado: (2019)

Identification and characterization of a subpopulation of CD133(+) cancer stem‐like cells derived from SK-UT-1 cells
por: Gao, Jiuping, et al.
Publicado: (2021)

CD133 Modulate HIF-1α Expression under Hypoxia in EMT Phenotype Pancreatic Cancer Stem-Like Cells
por: Maeda, Koki, et al.
Publicado: (2016)

Hypoxia-induced Tie1 drives stemness and cisplatin resistance in non-small cell lung carcinoma cells
por: Li, Chaojie, et al.
Publicado: (2021)

Pathological features of transplanted tumor established by CD133 positive TJ905 glioblastoma stem-like cells
por: Jin, Feng, et al.
Publicado: (2015)

Silencing of microRNA-135b inhibits invasion, migration, and stemness of CD24(+)CD44(+) pancreatic cancer stem cells through JADE-1-dependent AKT/mTOR pathway
por: Zhou, Jingyang, et al.
Publicado: (2020)

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
por: Zhou, Yang, et al.
Publicado: (2022)

Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells
por: Xue, Zhan-Xiong, et al.
Publicado: (2014)

Hypoxia-induced modulation of PTEN activity and EMT phenotypes in lung cancers
por: Kohnoh, Takashi, et al.
Publicado: (2016)

Beclin1 inhibition promotes autophagy and decreases gemcitabine–induced apoptosis in Miapaca2 pancreatic cancer cells
por: Li, Xiaoshu, et al.
Publicado: (2013)

Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling
por: Zhang, Zhengle, et al.
Publicado: (2018)

SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion
por: Zhang, Wei, et al.
Publicado: (2015)

Gambogic acid induces autophagy and combines synergistically with chloroquine to suppress pancreatic cancer by increasing the accumulation of reactive oxygen species
por: Wang, Hongcheng, et al.
Publicado: (2019)

Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell lines
por: Lee, Hyun Joo, et al.
Publicado: (2011)

Stress-induced endocytosis and degradation of epidermal growth factor receptor are two independent processes
por: Peng, Ke, et al.
Publicado: (2016)

ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cells
por: Chen, Haidi, et al.
Publicado: (2021)

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
por: Immervoll, Heike, et al.
Publicado: (2008)

Differential secretome of pancreatic cancer cells in serum-containing conditioned medium reveals CCT8 as a new biomarker of pancreatic cancer invasion and metastasis
por: Liu, Peng, et al.
Publicado: (2019)

Laparoscopic spleen-preserving hilar lymph node dissection through pre-pancreatic and retro-pancreatic approach in patients with gastric cancer
por: Zheng, Liansheng, et al.
Publicado: (2016)

Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis
por: Chen, Xuelian, et al.
Publicado: (2018)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

Establishment and characterization of 6 novel patient-derived primary pancreatic ductal adenocarcinoma cell lines from Korean pancreatic cancer patients
por: Kim, Mi-Ju, et al.
Publicado: (2017)

PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
por: Dou, Xiaoyan, et al.
Publicado: (2015)

Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
por: El Fitori, Jamael, et al.
Publicado: (2005)

Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer
por: Jiang, Dawei, et al.
Publicado: (2019)

Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy
por: Liu, Jingkai, et al.
Publicado: (2021)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIP(s)
por: Francois, Rony A., et al.
Publicado: (2019)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer
por: Ke, Mu-jing, et al.
Publicado: (2020)

Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer
por: Jiao, Feng, et al.
Publicado: (2020)

Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
por: Okamoto, Oswaldo Keith, et al.
Publicado: (2007)

CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

Cancer Stem Cells in Pancreatic Cancer
por: Bao, Qi, et al.
Publicado: (2010)

G-protein-signaling modulator 2 expression and role in a CD133(+) pancreatic cancer stem cell subset
por: Dang, Sheng-Chun, et al.
Publicado: (2019)

Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway
por: Zhou, Yongping, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n4au7ilue4jiac2p5l9i6q8g3p